Cargando…

The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity

Major depressive disorder (MDD) is a highly prevalent and disabling condition with a high disease burden. There are currently no validated biomarkers for the diagnosis and treatment of MDD. This study assessed serum amino acid metabolite changes between MDD patients and healthy controls (HCs) and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Cyrus Su Hui, Tay, Gabrielle Wann Nii, Wee, Hai Ning, Ching, Jianhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916471/ https://www.ncbi.nlm.nih.gov/pubmed/36768551 http://dx.doi.org/10.3390/ijms24032231

Ejemplares similares

Integration of the Cortical Haemodynamic Response Measured by Functional Near-Infrared Spectroscopy and Amino Acid Analysis to Aid in the Diagnosis of Major Depressive Disorder
por: Ong, Samantha K., et al.
Publicado: (2021)

The diagnostic and predictive potential of personality traits and coping styles in major depressive disorder
por: Ho, Cyrus S. H., et al.
Publicado: (2022)

The role of miRNA in diagnosing and clarifying the pathomechanisms in major depressive disorder
por: Ho, C. S., et al.
Publicado: (2023)

Bacterial Metabolites of Human Gut Microbiota Correlating with Depression
por: Averina, Olga V., et al.
Publicado: (2020)

Depression and Decay - A Case of Major Depressive Disorder with Psychotic Features in an Elderly Patient with Cancer
por: Wee Yun Qing, E.
Publicado: (2023)

Functional and structural brain correlates of risk for major depression in children with familial depression
por: Chai, Xiaoqian J., et al.
Publicado: (2015)

Microbial metabolites and immune regulation: New targets for major depressive disorder
por: Merchak, Andrea, et al.
Publicado: (2020)

Potential biomarkers of major depression diagnosis and chronicity
por: Galvão, Ana Cecília de Menezes, et al.
Publicado: (2021)

Brain aging in major depressive disorder
por: Han, L., et al.
Publicado: (2021)

Assessment of brain functional connectome alternations and correlation with depression and anxiety in major depressive disorders
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017)

Clinical Utility of Functional Near-Infrared Spectroscopy for Assessment and Prediction of Suicidality: A Systematic Review
por: Lee, Y. Q., et al.
Publicado: (2021)

Electrophysiological correlates of mindfulness in patients with major depressive disorder
por: Sarlon, Jan, et al.
Publicado: (2022)

Functional MRI correlates of emotion regulation in major depressive disorder related to depressive disease load measured over nine years
por: van Kleef, Rozemarijn S., et al.
Publicado: (2023)

Age-specific urinary metabolite signatures and functions in patients with major depressive disorder
por: Chen, Jian-Jun, et al.
Publicado: (2019)

Plasma metabolites were associated with spatial working memory in major depressive disorder
por: Du, Yue, et al.
Publicado: (2021)

Missed Diagnosis of Major Depressive Disorder with Catatonia Features
por: Jhawer, Harry, et al.
Publicado: (2019)

Therapeutic management of major depression and psoriazis dual diagnosis
por: Vasiliu, O.
Publicado: (2021)

The Neural Correlates of the Recognition of Emotional Intensity Deficits in Major Depression: An ERP Study
por: Li, Miao, et al.
Publicado: (2023)

Relationship of Anxiety and Depression with Respiratory Symptoms: Comparison between Depressed and Non-Depressed Smokers in Singapore
por: Ho, Cyrus SH, et al.
Publicado: (2019)

Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression
por: Karabatsiakis, A, et al.
Publicado: (2014)

A Genetic Susceptibility Mechanism for Major Depression: Combinations of polymorphisms Defined the Risk of Major Depression and Subpopulations
por: Wang, Yanfang, et al.
Publicado: (2015)

Distinctive Clinical Correlates of Psychotic Major Depression: The CRESCEND Study
por: Park, Seon-Cheol, et al.
Publicado: (2014)

Neural correlates of self-perceptions in adolescents with major depressive disorder
por: Bradley, Kailyn A.L., et al.
Publicado: (2016)

Prevalence and correlates of major depressive disorder: a systematic review
por: Gutiérrez-Rojas, Luis, et al.
Publicado: (2020)

Clinical correlates of stress, immune and metabolic markers in major depression
por: Soria, V.
Publicado: (2023)

An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder
por: Pu, Juncai, et al.
Publicado: (2020)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
por: Ikenouchi, Atsuko, et al.
Publicado: (2021)

Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder
por: Zhang, Han-ping, et al.
Publicado: (2020)

Pupil Dilation during Reward Anticipation Is Correlated to Depressive Symptom Load in Patients with Major Depressive Disorder
por: Schneider, Max, et al.
Publicado: (2020)

Assessing Neurocognition (P300) and Correlating Them to Depression Rating Scales in Patients With Major Depressive Disorder
por: Wakode, Santosh, et al.
Publicado: (2022)

Core symptoms of major depressive disorder: relevance to diagnosis and treatment
por: Kennedy, Sidney H.
Publicado: ( 200)

High-order brain functional network for electroencephalography-based diagnosis of major depressive disorder
por: Zhao, Feng, et al.
Publicado: (2022)

Common Brain Networks Between Major Depressive-Disorder Diagnosis and Symptoms of Depression That Are Validated for Independent Cohorts
por: Yamashita, Ayumu, et al.
Publicado: (2021)

The Genetics of Major Depression
por: Flint, Jonathan, et al.
Publicado: (2014)

The Genetics of Major Depression
por: Flint, Jonathan, et al.
Publicado: (2014)

Molecular Signatures of Major Depression
por: Cai, Na, et al.
Publicado: (2015)

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder
por: Sobocki, P, et al.
Publicado: (2008)

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
por: Yoshimura, Reiji, et al.
Publicado: (2019)

Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder
por: Bai, Shunjie, et al.
Publicado: (2021)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder – RETRACTION
por: Ikenouchi, Atsuko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08qp7qd8edt5pc1d3mdauifdfd